Biphasic high-grade cerebellar glioma with epithelial-like components: challenges in integrated diagnosis imposed by limited sampling [0.03%]
Yasuhide Takeuchi,Akihiko Sakata,Masahiro Tanji et al.
Yasuhide Takeuchi et al.
Correction: Comparative molecular profiles of distinct tumor components in recurrent tentorial meningioma after stereotactic radiosurgery: a case report implicating acquired aggressive alterations associated with WHO grade progression [0.03%]
复发性脑膜瘤经立体定向放射手术后不同肿瘤成分的分子特征比较：一例报告指出与WHO分级进展相关的获得性恶性表型
Takeru Hirata,Yudai Hirano,Motoyuki Umekawa et al.
Takeru Hirata et al.
Published Erratum
Brain tumor pathology. 2026 Apr 5. DOI:10.1007/s10014-026-00535-5 2026
Prognostic significance of CDKN2A/B hemizygous deletion in IDH-mutant astrocytomas: a systematic review and meta-analysis [0.03%]
IDH突变型胶质瘤中CDKN2A/B单倍体缺失的预后意义：系统评价和 Meta 分析
Satoshi Nakasu,Shoichi Deguchi,Mónica Mezmezian et al.
Satoshi Nakasu et al.
Molecular analysis of a gliosarcoma with distinct oligodendroglioma and sarcomatous components ("Oligosarcoma") [0.03%]
具有明显寡胶质瘤和肉瘤成分的gliosarcoma的分子分析（“oligosarcoma”）
Shoh Sasaki,Maki Sakaguchi,Maiko Takeda et al.
Shoh Sasaki et al.
Rare intracranial mesenchymal tumors with FET::CREB fusions: clinicopathologic spectrum of four cases with integrated molecular analysis and review of the literature [0.03%]
FET::CREB融合的罕见颅内间叶源性肿瘤：四例综合分子分析的临床病理谱及文献回顾
Xiaoqun Ba,Wanli Huang,Shufen Liu et al.
Xiaoqun Ba et al.
Utility of digital PCR for detecting TERT promoter mutations and CDKN2A homozygous deletion in meningioma [0.03%]
液体芯片技术检测脑膜瘤TERT启动子突变和CDKN2A等位基因丢失的可行性研究
Takuma Kodama,Yuzaburo Shimizu,Mario Suzuki et al.
Takuma Kodama et al.
Feasibility of long-read nanopore sequencing for methylation-based classification of posterior fossa ependymomas [0.03%]
基于甲基化的后颅窝室管膜瘤分类的纳米孔长读段测序可行性研究
Seiji Yamada,Tetsuya Takimoto,Yoshiteru Shimoda et al.
Seiji Yamada et al.
Diffuse low-grade glioma with a rare BRAF p.T599dup mutation in a child: importance of clinicopathological and molecular correlation [0.03%]
一例罕见BRAF c.1796_1800dupC(p.T599dup)突变的弥散性低级别胶质瘤患儿：临床病理及分子相关性的意义
Seiji Yamada,Akio Takahashi,Hideaki Yokoo
Seiji Yamada
Diverse NF2 alterations in cranial schwannomas: a two-case series of germline whole-gene deletion and somatic in-frame deletion [0.03%]
神经纤维瘤病2型的不同类型改变在颅内施万细胞瘤中的研究：两项系列病例报告，分别为胚系整个基因缺失和体细胞嵌合型缺失
Kohei Nakamura,Ryota Tamura,Junki Sogano et al.
Kohei Nakamura et al.
NF2-related schwannomatosis is a tumor predisposition syndrome caused by diverse NF2 alterations, including truncating variants, copy-number changes, and non-truncating variants such as in-frame indels. Molecular and clinical correlations o...
Unveiling a genetic rarity: intracranial sarcomatous tumor with EWSR1::PATZ1 fusion-a case report and review of the literature [0.03%]
揭开罕见的遗传异常：带有EWSR1::PATZ1融合基因的颅内肉瘤一例报告及文献回顾
Swati Mahajan,Jyotsna Singh,Ashwinee Kumar et al.
Swati Mahajan et al.